These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Human cytomegalovirus in cancer: the mechanism of HCMV-induced carcinogenesis and its therapeutic potential. Yu C; He S; Zhu W; Ru P; Ge X; Govindasamy K Front Cell Infect Microbiol; 2023; 13():1202138. PubMed ID: 37424781 [TBL] [Abstract][Full Text] [Related]
4. Anti-arthritic effects of geranium essential oil loaded chitosan nanoparticles in Freund's complete adjuvant induced arthritic rats through down-regulation of inflammatory cytokines. Naseer RD; Muhammad F; Aslam B; Faisal MN Inflammopharmacology; 2023 Aug; 31(4):1893-1912. PubMed ID: 37231284 [TBL] [Abstract][Full Text] [Related]
5. Anti-COVID-19 Credentials of Chitosan Composites and Derivatives: Future Scope? Gopal J; Muthu M; Pushparaj SSC; Sivanesan I Antibiotics (Basel); 2023 Mar; 12(4):. PubMed ID: 37107027 [TBL] [Abstract][Full Text] [Related]
6. Advances in Antiviral Delivery Systems and Chitosan-Based Polymeric and Nanoparticulate Antivirals and Antiviral Carriers. Žigrayová D; Mikušová V; Mikuš P Viruses; 2023 Feb; 15(3):. PubMed ID: 36992356 [TBL] [Abstract][Full Text] [Related]
8. Antiviral role of nanomaterials: a material scientist's perspective. Aanish Ali M; Rehman N; Park TJ; Basit MA RSC Adv; 2022 Dec; 13(1):47-79. PubMed ID: 36605642 [TBL] [Abstract][Full Text] [Related]
9. Relationship between the Antifungal Activity of Chitosan-Capsaicin Nanoparticles and the Oxidative Stress Response on Hernández-Téllez CN; Luque-Alcaraz AG; Núñez-Mexía SA; Cortez-Rocha MO; Lizardi-Mendoza J; Rosas-Burgos EC; Rosas-Durazo AJ; Parra-Vergara NV; Plascencia-Jatomea M Polymers (Basel); 2022 Jul; 14(14):. PubMed ID: 35890550 [TBL] [Abstract][Full Text] [Related]
10. Towards the Antiviral Agents and Nanotechnology-Enabled Approaches Against Parvovirus B19. Hu X; Jia C; Wu J; Zhang J; Jiang Z; Ma K Front Cell Infect Microbiol; 2022; 12():916012. PubMed ID: 35795188 [TBL] [Abstract][Full Text] [Related]
11. Chitosan Nanoparticles in Atherosclerosis-Development to Preclinical Testing. Sriamornsak P; Dass CR Pharmaceutics; 2022 Apr; 14(5):. PubMed ID: 35631521 [TBL] [Abstract][Full Text] [Related]
15. Potential of mucoadhesive chitosan glutamate microparticles as microbicide carriers - antiherpes activity and penetration behavior across the human vaginal epithelium. Szymańska E; Krzyżowska M; Cal K; Mikolaszek B; Tomaszewski J; Wołczyński S; Winnicka K Drug Deliv; 2021 Dec; 28(1):2278-2288. PubMed ID: 34668816 [TBL] [Abstract][Full Text] [Related]
16. A review of the antiviral activity of Chitosan, including patented applications and its potential use against COVID-19. Jaber N; Al-Remawi M; Al-Akayleh F; Al-Muhtaseb N; Al-Adham ISI; Collier PJ J Appl Microbiol; 2022 Jan; 132(1):41-58. PubMed ID: 34218488 [TBL] [Abstract][Full Text] [Related]
17. Preparation and Antimicrobial Activity of Chitosan and Its Derivatives: A Concise Review. Confederat LG; Tuchilus CG; Dragan M; Sha'at M; Dragostin OM Molecules; 2021 Jun; 26(12):. PubMed ID: 34204251 [TBL] [Abstract][Full Text] [Related]
18. Development of nanoparticle-delivery systems for antiviral agents: A review. Delshadi R; Bahrami A; McClements DJ; Moore MD; Williams L J Control Release; 2021 Mar; 331():30-44. PubMed ID: 33450319 [TBL] [Abstract][Full Text] [Related]
19. The Correlation between Physical Crosslinking and Water-Soluble Drug Release from Chitosan-Based Microparticles. Szymańska E; Woś-Latosi K; Jacyna J; Dąbrowska M; Potaś J; Markuszewski MJ; Winnicka K Pharmaceutics; 2020 May; 12(5):. PubMed ID: 32429349 [TBL] [Abstract][Full Text] [Related]
20. An overview of functional nanoparticles as novel emerging antiviral therapeutic agents. Chen L; Liang J Mater Sci Eng C Mater Biol Appl; 2020 Jul; 112():110924. PubMed ID: 32409074 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]